These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22280816)

  • 1. Recent advances in antitubercular natural products.
    García A; Bocanegra-García V; Palma-Nicolás JP; Rivera G
    Eur J Med Chem; 2012 Mar; 49():1-23. PubMed ID: 22280816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial natural products--an opportunity for the Colombian biodiversity.
    Bueno J; Coy ED; Stashenko E
    Rev Esp Quimioter; 2011 Dec; 24(4):175-83. PubMed ID: 22173186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural product growth inhibitors of Mycobacterium tuberculosis.
    Copp BR; Pearce AN
    Nat Prod Rep; 2007 Apr; 24(2):278-97. PubMed ID: 17389998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug development against tuberculosis: Impact of alkaloids.
    Mishra SK; Tripathi G; Kishore N; Singh RK; Singh A; Tiwari VK
    Eur J Med Chem; 2017 Sep; 137():504-544. PubMed ID: 28628823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial plant terpenoids.
    Cantrell CL; Franzblau SG; Fischer NH
    Planta Med; 2001 Nov; 67(8):685-94. PubMed ID: 11731906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis drugs: ten years of research.
    Janin YL
    Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
    Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
    Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives on natural products in TB drug research.
    Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
    Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspectives in drug discovery against tuberculosis from natural products.
    Nguta JM; Appiah-Opong R; Nyarko AK; Yeboah-Manu D; Addo PG
    Int J Mycobacteriol; 2015 Sep; 4(3):165-83. PubMed ID: 27649863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaloids as potential anti-tubercular agents.
    Kishore N; Mishra BB; Tripathi V; Tiwari VK
    Fitoterapia; 2009 Apr; 80(3):149-63. PubMed ID: 19344681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active drugs against Mycobacterium tuberculosis].
    Coll P
    Enferm Infecc Microbiol Clin; 2009 Oct; 27(8):474-80. PubMed ID: 19766360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyridazino[4,3-b]indoles with dual inhibitory activity against Mycobacterium tuberculosis and monoamine oxidase.
    Velezheva VS; Brennan PJ; Marshakov VY; Gusev DV; Lisichkina IN; Peregudov AS; Tchernousova LN; Smirnova TG; Andreevskaya SN; Medvedev AE
    J Med Chem; 2004 Jun; 47(13):3455-61. PubMed ID: 15189042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
    Baylan O
    Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitubercular activity of new coumarins.
    Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
    Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.